6699 — Angelalign Technology Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual cashflow statement for Angelalign Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	84.5	191	332	252	—
Depreciation
Amortisation
Non-Cash Items	61.6	69.1	11.2	-40.5	—
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	228	116	59.3	-130	166
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	402	408	442	147	166
Capital Expenditures	-99.7	-41.7	-200	-95.4	-115
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3.31	34.4	17.7	-64.4	-867
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-103	-7.28	-182	-160	-982
Financing Cash Flow Items	-2.27	-56.2	-132	-1.68	-8.02
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-11.3	-23.3	2,523	-194	-187
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	289	373	2,749	22.4	-960